Revolutionizing the treatment of bacterial disease
Founded 2015
Partnered 2017
Paul Garofolo
Dave Ousterout
Stuart Peterson
Austin Walne (observer)
Designing and developing powerful antimicrobials that avoid currently known antibiotic resistance mechanisms while leaving non-target bacteria unharmed